2012
DOI: 10.1111/j.1467-2995.2011.00681.x
|View full text |Cite
|
Sign up to set email alerts
|

Development of a romifidine constant rate infusion with or without butorphanol for standing sedation of horses

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

2
45
1
1

Year Published

2013
2013
2023
2023

Publication Types

Select...
5
3

Relationship

1
7

Authors

Journals

citations
Cited by 48 publications
(49 citation statements)
references
References 22 publications
2
45
1
1
Order By: Relevance
“…1992). The CRI dosages have been developed using exactly the same materials and methods and have been shown to provide constant plasma concentrations (Ringer et al. 2012a,b).…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…1992). The CRI dosages have been developed using exactly the same materials and methods and have been shown to provide constant plasma concentrations (Ringer et al. 2012a,b).…”
Section: Discussionmentioning
confidence: 99%
“…The alpha 2 ‐adrenergic agonists xylazine and romifidine both have a marketing authorization for horses in many countries. CRI protocols providing prolonged sedation and constant plasma concentrations have been developed previously (Ringer et al. 2012a,b).…”
Section: Introductionmentioning
confidence: 99%
“…CRI is to maintain steady plasma drug concentrations, leading to consistent sedation and analgesia. Infusions of a 2 -agonists alone [3][4][5][6] or in combination with opioids [4][5][6][7] are commonly used for this purpose.…”
Section: Introductionmentioning
confidence: 99%
“…To investigate all methods over a range of CO, 3 levels were studied: baseline (no treatment), high CO, and low CO. After baseline measurements, high CO was induced with an intravenous continuous rate infusion (CRI) of dobutamine (3 μg/kg/min), started 10 minutes before CO measurements and was discontinued after high CO data were collected . After a 45‐minute wash‐out period, low CO was induced with an intravenous romifidine bolus (80 μg/kg), immediately followed by a CRI at 30 μg/kg/h . Low CO data were collected 15 minute after initiating the romifidine CRI, which coincided with expected steady‐state plasma concentrations and clinical effects .…”
Section: Methodsmentioning
confidence: 99%
“…After a 45‐minute wash‐out period, low CO was induced with an intravenous romifidine bolus (80 μg/kg), immediately followed by a CRI at 30 μg/kg/h . Low CO data were collected 15 minute after initiating the romifidine CRI, which coincided with expected steady‐state plasma concentrations and clinical effects . For each level, lithium dilution CO was measured twice.…”
Section: Methodsmentioning
confidence: 99%